2021
2020
2019
1
2
3
→
Odyssey Group International, Inc. Closes Acquisition of Novel Concussion Drug
Mar 2, 2021
Odyssey Group International Completes Design Phase and Moves Into Prototype Phase for Its Save A Life Choking Rescue Device
Feb 24, 2021
Odyssey Group International/Prevacus, Inc. Reports Brain Bio-Distribution Findings of PRV-002
Feb 17, 2021
Odyssey Group International Announces Recent Television Segments on Fox Business, CheddarTV and Newsmax
Feb 9, 2021
Odyssey Group International's Planned Acquisition of Concussion Drug from Prevacus, Inc. Enhances Delivery Capabilities with Nasal Therapeutic
Jan 26, 2021
Odyssey Group International's Planned Acquisition of Concussion Drug from Prevacus, Inc. Provides Positive Data from Ongoing Stability Studies
Jan 20, 2021
Odyssey Group International to Acquire Concussion Drug Asset from Prevacus, Inc.
Jan 11, 2021
Odyssey Group International Advances Development of its Save A Life Choking Rescue Device
Dec 16, 2020
Odyssey Group International Provides Fiscal Year End July 31, 2020 Update
Dec 7, 2020
Odyssey Group International Announces $10,250,000 Common Stock Purchase Agreement with Lincoln Park Capital Fund to Support its Long-Term Growth
Aug 20, 2020